---
created: 2025-04-13
updated: 2025-04-13T10:51
id: e)YmXE6S6b
specialty: cardio
specialty_id: 108
tags:
  - source/ak-original-decks::step-1::zanki-pharmacology
  - source/ak-step1-v11::
  - theme/b&b::05-cardio::04-arrhythmias::06-antiarrhythmic-drugs
  - source/ak-step1-v11::
  - theme/firstaid::07-cardiovascular::05-pharm::12-16-antiarrythmics::15-class-4-calcium-channel-blockers
  - source/ak-step1-v11::
  - theme/ome::09-cardiac::04-electricity::05-anti-arrhythmics
  - source/ak-step1-v11::
  - source/ome-banner::basic-science::09-cardiac::25-arrhythmias
  - source/ak-step1-v11::
  - theme/physeo::09-pharm::10-cardiac::20-class-iv-antiarrhythmics
  - source/ak-step1-v11::
  - theme/sketchypharm::02-cardio-&-renal::04-antiarrhythmics::04-class-iv
  - source/ak-step1-v11::
  - theme/uworld::1000-9999::1000-1999::1973
  - source/ak-step1-v11::^other::^highyield::2-relativelyhighyield
  - source/ak-step1-v11::^systems::cardio::pharmacology
  - source/ak-step2-v11::
  - theme/b&b::01-cardiology::pharm::cvs-pharm-1"
type: flashcard
---

# Question
Class IV antiarrhythmics decrease pacemaker activity by decreasing the slope of phase **0** of the nodal action potential

---

# Answer
Class IV antiarrhythmics of importance (verapamil and diltiazem) are L type selective, and thus decrease the slope of phase 0 (the Ca2+ dependent upstroke of nodal cells)